Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.
- NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_assertion description "[The detection of a wide distribution of bombesin/GRP receptors in human prostate carcinomas supports the view that they may be involved in modulation of tumor progression and suggests that approaches based on binding of bombesin receptor antagonists or new targeted cytotoxic bombesin analogs to prostate cancers could be considered for the therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.
- NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_assertion evidence source_evidence_literature NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.
- NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_assertion SIO_000772 10679759 NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.
- NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_assertion wasDerivedFrom befree-2016 NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.
- NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_assertion wasGeneratedBy ECO_0000203 NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.
- befree-2016 importedOn "2016-02-19" NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.